Budget Impact Analysis Comparing Blinatumomab In The Treatment Of Adults With Philadelphia Chromosome-Negative Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (All) With Flag-Ida And Hyper CVAD
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.856
https://www.valueinhealthjournal.com/article/S1098-3015(17)31190-7/fulltext
Title :
Budget Impact Analysis Comparing Blinatumomab In The Treatment Of Adults With Philadelphia Chromosome-Negative Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (All) With Flag-Ida And Hyper CVAD
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31190-7&doi=10.1016/j.jval.2017.08.856
First page :
A549
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
813